Core Viewpoint - As of August 28, no listed companies have disclosed any increase in shareholding, while 21 companies have announced share reductions by their shareholders [1]. Summary by Category Share Reduction Announcements - Keg Precision Machinery: Controlling shareholder plans to reduce holdings by up to 3% [2] - Oulu Tong: Controlling shareholder and actual controller's concerted action party plans to reduce holdings by up to 1.74% [2] - Nanmo Biology: Plans to reduce repurchased shares by up to 1% of total share capital [2] - Weike Technology: Three shareholders plan to transfer a total of 2.99% of total share capital [2] - Jino Medical: Shareholder plans to reduce holdings by up to 0.04% [2] - Zhejiang Shiyu: Controlling shareholder plans to reduce holdings by up to 2% [2] - Zhongke Tongda: Shareholder Wuhan Gaoke plans to reduce holdings by up to 1% [2] - Chunzong Technology: Multiple shareholders plan to reduce holdings by up to 2% [2] - Wantong Expressway: Shareholder China Merchants Highway plans to reduce holdings by up to 3% [2] - Tai Rui Machinery: Actual controller Zheng Jianguo plans to reduce holdings by up to 2.95% [2] - Haotong Technology: Actual controller Xia Jun and specific shareholder Xuzhou Botong plan to reduce holdings by up to 3% [2] - Changsheng Bearing: Some senior management plans to reduce holdings by up to 1.2% [2] - Dongtian Micro: Shareholder plans to reduce holdings by up to 0.57% [2] - Aojie Technology: Shareholder Ali Network plans to reduce holdings by up to 3% [2] - Bocheng Shares: Some directors and senior management plan to reduce holdings [2] - Rongtai Shares: Shareholder Tai'an Runtu plans to reduce holdings by up to 1.05% [2] - Shangwei New Materials: Jinfeng Investment Holdings has completed the reduction of 4.0336 million shares [2] - Zhongchu Logistics: Senior management member Chu Xuri plans to reduce holdings by up to 0.09% [2] - Hengsheng Energy: One of the actual controllers, Gan Shunxian, plans to reduce holdings by up to 2% [2] - Jinghua New Materials: Controlling shareholder plans to reduce holdings by up to 3.01% [2] - New Coordinates: Shareholder plans to reduce holdings by up to 1% [2]

证券代码：688108 证券简称：赛诺医疗 公告编号：2025-041 赛诺医疗科学技术股份有限公司 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 大股东持有公司股份的基本情况 因自身资金周转需要，公司 5%以上股东郭彦超先生拟于本减持计划公告之日起 15 个交易 日之后的 3 个月内（2025 年 9 月 22 日至 2025 年 12 月 21 日），通过大宗交易方式减持合计不 超过 168,000 股的公司股份，减持股份占公司总股本的比例不超过 0.04%。 | 股东名称 | 郭彦超 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 | □否 | | | 直接持股 5%以上股东 | √是 | □否 | | | 董事、监事和高级管理人员 | □是 | □否 | | | 其他： | | | | 持股数量 | 20,840,854股 | | | | 持股比例 | 5.01% | | | | 当前 ...

Group 1 - The core viewpoint of the report is that Open Source Securities has given a "buy" rating for Sino Medical (688108.SH) based on its recent developments and market potential [1] - The intracranial self-expanding drug-eluting stent has entered the FDA's green channel, indicating that the neurointerventional business is entering a harvest period [1] - The coronary business is progressing smoothly with domestic centralized procurement, and there is potential for accelerated expansion in overseas markets [1]

医药生物/医疗器械 赛诺医疗（688108.SH） 2025H1 业绩符合预期，神介业务步入收获期 2025 年 08 月 28 日 投资评级：买入（维持） | 日期 | 2025/8/27 | | --- | --- | | 当前股价(元) | 30.23 | | 一年最高最低(元) | 47.00/7.35 | | 总市值(亿元) | 125.77 | | 流通市值(亿元) | 125.77 | | 总股本(亿股) | 4.16 | | 流通股本(亿股) | 4.16 | | 近 3 个月换手率(%) | 394.21 | 股价走势图 数据来源：聚源 -120% 0% 120% 240% 360% 480% 2024-08 2024-12 2025-04 赛诺医疗 沪深300 相关研究报告 《高端介入领域十余年耕耘，创新助 力业绩腾飞—公司首次覆盖报告》 -2025.2.21 风险提示：产品研发、注册不及预期，贸易摩擦及汇率波动，带量采购风险。 财务摘要和估值指标 | 指标 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- ...

证券之星消息，截至2025年8月27日收盘，赛诺医疗(688108)报收于30.23元，下跌4.94%，换手率 12.07%，成交量50.21万手，成交额15.64亿元。 8月27日的资金流向数据方面，主力资金净流出2.73亿元，占总成交额17.43%，游资资金净流入2417.81 万元，占总成交额1.55%，散户资金净流入2.48亿元，占总成交额15.89%。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： | 指标 | 赛诺医疗 | 医疗器械行业均值 | 行业排名 | | --- | --- | --- | --- | | 总市值 | 125.77亿元 | 120.81亿元 | 28 123 | | 净资产 | 9.25亿元 | 38.93亿元 | 105 123 | | 净利润 | 1384.16万元 | 1.4亿元 | 81 123 | | 市盈率(动) | 454.32 | 73.16 | 94 123 | | 市净率 | 14.07 | 3.9 | 121 123 | | 毛利率 | 63.64% | 51.64% | 41 123 | | 净利率 | 5.48% | 11.01% | ...

| 股票名称 | 监控开始日期 监控结束日期 异动开始日期 | | --- | --- | | *ST高鸿 | 2025-08-26 2025-09-08 未披露 | | 000851 | | | 思泉新材 | 2025-08-22 2025-09-04 未披露 | | 301489 | | | *ST苏吴 | 2025-08-21 2025-09-03 未披露 | | 600200 | | | 赛诺医疗 | 2025-08-19 2025-09-01 2025-08-07 | | 688108 | | | 赛诺医疗 | 2025-08-18 2025-08-29 2025-08-07 | | 688108 | | | 东芯股份 | 2025-08-18 2025-08-29 2025-07-07 | | 688110 | | | 淳中科技 | 2025-08-15 2025-08-28 未披露 | | 603516 | | *免责声明：文章内容仅供参考，不构成投资建议 *风险提示：股市有风险，入市需谨慎 ...

New Stock Offerings - Shenke Co., Ltd. (002633) has an offer period from July 29, 2025, to August 27, 2025[1] - Fushun Special Steel (600399) has an offer period from August 12, 2025, to September 10, 2025[1] - ST Gaohong (000851) has an announcement on August 26, 2025[1] Market Volatility - Great Wall Military Industry (601606) reported severe abnormal fluctuations on August 14, 2025[1] - Dongxin Co., Ltd. (688110) had an announcement on August 16, 2025, regarding market conditions[1] - Changfei Optical Fiber (601869) has an announcement dated August 27, 2025, related to market performance[1] Company Announcements - ST Dehao (002005) has an announcement on August 27, 2025, regarding its market status[1] - China Satellite (600118) announced updates on August 27, 2025[1] - ST Yizhong (603389) has an announcement dated August 26, 2025, regarding its market activities[1]

New Stock Issuance - The new stock issuance for Sanxie Electric (证券代码: 920100) is priced at 8.83[1] - Shenkou Co. (证券代码: 002633) has a tender offer period from July 29, 2025, to August 27, 2025[1] - Fushun Special Steel (证券代码: 600399) has a tender offer period from August 12, 2025, to September 10, 2025[1] Market Alerts - Changcheng Military Industry (证券代码: 601606) is experiencing severe abnormal fluctuations[1] - ST Yanzhen (证券代码: 603389) has reported significant trading anomalies[1] - ST Zhongdi (证券代码: 000609) has been flagged for unusual trading activity[1] Other Notable Stocks - Zhanjiang Development (证券代码: 000753) and Pudong Construction (证券代码: 600284) are also under scrutiny for trading irregularities[1] - The stock of Zhaoyi Innovation (证券代码: 603986) is being monitored for potential volatility[1] - The stock of ST Suwu (证券代码: 600200) has been highlighted for its trading behavior[1]

证券代码：688108 证券简称：赛诺医疗 公告编号：2025-039 赛诺医疗科学技术股份有限公司 关于子公司产品获得国内医疗器械 注册证的自愿性披露公告 重要内容提示： 近日，赛诺医疗科学技术股份有限公司（以下简称"赛诺医疗"或"公司"）控股子公司赛诺神畅医疗科技 有限公司（以下简称"赛诺神畅"）收到国家药品监督管理局（以下简称"国家药监局"）颁发的《中华人 民共和国医疗器械注册证》，现将相关情况公告如下： 一、《医疗器械注册证》内容 注册证编号：国械注准20253031686 产品名称：一次性使用微导管 结构及组成: 该产品由微导管和塑形针组成。产品经环氧乙烷灭菌，一次性使用，货架有效期2年。 适用范围：该产品用于一般性血管内操作，包括在神经血管内输注诊断性制剂(造影剂)和适当的器械(弹 簧圈、支架)。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 二、医疗器械基本情况 本次获得《医疗器械注册证》的一次性使用微导管，是由公司控股子公司赛诺神畅自主研发并进行生产 的一款导管产品。该产品为单腔器械，有半刚性的近端部分和 ...

截至2025年8月25日收盘，赛诺医疗股价报33.38元，较前一交易日上涨0.68元，涨幅2.08%。当日成交 额23.07亿元，换手率16.47%。 赛诺医疗属于医疗器械行业，专注于高端介入医疗器械的研发、生产和销售。公司主要产品包括冠脉支 架、球囊导管等，其控股子公司赛诺神畅医疗科技有限公司近日获得国家药监局颁发的一次性使用微导 管医疗器械注册证，该产品适用于神经血管内操作。 风险提示：市场有风险，投资需谨慎。 来源：金融界 消息面上，赛诺医疗公告称，其子公司获得一次性使用微导管注册证，注册证有效期至2030年8月21 日。此外，公司2025年中期实现营收2.40亿元，归母净利润1384万元。 资金流向方面，8月25日主力资金净流出1.07亿元，近五日主力资金累计净流出14.54亿元。 ...